Inactivated vaccine · VDDBV0259
Note: 3 additional source trials listed this vaccine in studies of unrelated viruses (e.g. as a comparator, adjunct, or in coadministration trials with other vaccines). Those trials are not shown here.
| NCT ID | Phase | Disease / Condition |
|---|---|---|
| NCT00558649 | — | Influenza, Human |
| NCT00442975 | Approved | Influenza |
| NCT00100399 | Phase 3 | Influenza |
| NCT00345904 | Phase 3 | Influenza |
| NCT05315024 | — | Influenza |
| NCT00386113 | Phase 2 | Influenza |
| NCT01702454 | Phase 3 | Influenza |
| NCT02369341 | Phase 3 | Influenza |
| NCT00363870 | Approved | Influenza |
| NCT01607112 | Phase 3 | Influenza |
| NCT01884519 | Phase 3 | Influenza |
| NCT01878812 | Phase 3 | Influenza |
| NCT00386698 | Phase 2 | Influenza |
| NCT00377585 | Phase 2 | Influenza |
| NCT00318149 | Phase 2 | Influenza |
| NCT00764790 | Phase 3 | Influenza |
| NCT00529516 | Phase 3 | Influenza |
| NCT00750360 | Approved | Influenza |
| NCT01190215 | Approved | Influenza |
| NCT00377611 | Approved | Influenza |
| NCT00706563 | Phase 3 | Influenza |
| NCT01144299 | Phase 3 | Influenza |
| NCT00920374 | Phase 3 | Influenza |
| NCT00476307 | Phase 3 | Influenza |
| NCT00383123 | Phase 3 | Influenza |
| NCT00538213 | Phase 2 | Influenza |
| NCT00374842 | Phase 2 | Influenza |
| NCT01196026 | Approved | Influenza |
| NCT00318058 | Phase 1 | Influenza |